Mr. Samuel M. Liang is no longer serves as Executive Vice President of Hanger, Inc., President and Chief Operating Officer of Hanger Prosthetics & Orthotics, Inc. (dba Hanger Clinic) of the Company effective 11/13/2020. Mr. Liang joined our Company in May 2014 as Executive Vice President. Between May 2010 and May 2014, Mr. Liang was a Senior Vice President of Bayer HealthCare where he served as President and CEO of MEDRAD, Inc. and Head of the Radiology & Interventional business. Prior to that, he served as President and Chief Executive Officer of Vascular Therapies, LLC, a company that created a combination drug and device product for vascular surgery. Mr. Liang also held numerous leadership positions over 24 years at Cordis Corporation, a Johnson & Johnson company. Mr. Liang earned a B.S.E. degree in mechanical engineering and material from Duke University, North Carolina, and a master’s degree in management from the Kellogg Graduate School of Management, Northwestern University, Illinois.
As the of Hanger Inc, the total compensation of Samuel Liang at Hanger Inc is $1,341,440. There are 2 executives at Hanger Inc getting paid more, with Vinit Asar having the highest compensation of $4,940,250.
Samuel Liang is 57, he's been the of Hanger Inc since . There are 11 older and 13 younger executives at Hanger Inc. The oldest executive at Hanger Inc is Richard Pettingill, 71, who is the Independent Director.
Samuel's mailing address filed with the SEC is 10910 DOMAIN DRIVE, SUITE 300, , AUSTIN, TX, 78758.
Over the last 7 years, insiders at Hanger Inc have traded over $2,332,397 worth of Hanger Inc stock and bought 2,700 units worth $51,246 . The most active insiders traders include Thomas C Freyman, Stephen E Hare és Cynthia L Lucchese. On average, Hanger Inc executives and independent directors trade stock every 72 days with the average trade being worth of $339,319. The most recent stock trade was executed by Thomas E Kiraly on 15 March 2022, trading 8,750 units of HNGR stock currently worth $167,650.
About Hanger, Inc.- Hanger, Inc. delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics withapproximately 800locationsnationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With nearly 160 years of clinical excellence and innovation, Hanger's vision is to lead the orthotic and prosthetic markets by providing superior patient care, outcomes, services and value.
Hanger Inc executives and other stock owners filed with the SEC include: